PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares... Read more

European Commission approves Roche’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer

Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC Conditional approval is based on results from the phase I/II ARROW study, in which Gavreto led to durable responses in people with RET fusion-positive advanced NSCLC Basel, 19 November 2021 – Roche (SIX:... Read more

Bruker Announces Acquisition of MOLECUBES NV

Expands Nuclear Molecular Imaging Portfolio with Modular Benchtop CUBES™ PET, SPECT and CT Preclinical Imaging Systems GHENT, Belgium–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and... Read more

Xylem Announces New Investor Relations Leadership

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 18, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company, today announced a change in the leadership of its Investor Relations team. Matthew Latino, currently Vice President, Investor Relations, is appointed Vice President, Finance, of Xylem’s Applied Water Systems (AWS) business and the Americas Commercial Team (ACT), effective January... Read more

Roche launches cobas 5800, a new molecular diagnostics system to expand access to testing and improve patient care

Infectious diseases, such as those infections transmitted via respiratory, sexually and transplant, are becoming increasingly difficult to manage and represent an ever-growing medical need for millions of patients worldwide. Access to accurate and reliable diagnostic tests help clinicians improve patient care, limit healthcare spending and contribute to protecting public health. The cobas 5800 System is... Read more

Karolinska Institutet & MedTechLabs Kickoff The World’s First Clinical Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

Photon counting CT has the promise to further expand the capabilities of traditional CT Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting The project is the result of close collaborations between healthcare, academia and business Chicago,... Read more

Karolinska Institutet & MedTechLabs Kickoff The World’s First Clinical Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

Photon counting CT has the promise to further expand the capabilities of traditional CT Karolinska Institutet and MedTechLabs’ pilot study represents the first of its kind to test pure silicon CT detector technology for photon counting CT in a clinical setting The project is the result of close collaborations between healthcare, academia and business Chicago,... Read more

Brooks Automation Announces Planned Name and Stock Ticker Symbol Change – Azenta, Inc. (Nasdaq: AZTA) Set to Begin Trading Effective December 1st

Brooks Automation Announces Planned Name and Stock Ticker Symbol Change – Azenta, Inc. (Nasdaq: AZTA) Set to Begin Trading Effective December 1st CHELMSFORD, Mass., Nov. 16, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) announced at its investor day earlier today that it is changing its name to Azenta, Inc. and will begin trading on Nasdaq... Read more

PacBio Launches HiFiViral SARS-CoV-2 Kit and Microbial Whole Genome Sequencing Enhancements to Combat Infectious Disease and Strengthen Public Health Response to Pathogen Threats

MENLO PARK, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the launch of the HiFiViral SARS-CoV-2 Kit – a fully kitted end-to-end solution for COVID-19 surveillance, which public health laboratories can use to identify new SARS-CoV-2 variants and detect all variants circulating... Read more